澤瀉가 유리지방산으로 유발된 HepG2 cell의 lipoapoptosis에 미치는 영향
The Effect of Alisma orientale Extract on Free Fatty Acid-induced Lipoapoptosis in HepG2 Cells
0
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Objectives : This study was designed to investigate the effect on lipoapoptosis of Alisma orientale extract against free fatty acid-induced cellular injury. Methods : HepG2 cells were used in an vitro model. HepG2 cells were treated with free fatty acids to generate a cellular model of nonalcoholic fatty liver disease (NAFLD). Using this cellular model, the anti-apoptotic effect and reducing steatosis of Alisma orientale extract against free fatty acid-induced cellular injury was evaluated by measuring steatosis and apoptosis. Results : Alisma orientale extract significantly attenuated free fatty acid-induced intracellular steatosis. Alisma orientale extract inhibited free fatty acid-mediated activation of pJNK, PUMA, BAX, caspase-3, and –9, and apoptotic kinases that are correlated with NAFLD. Alisma orientale extract also promoted Bcl-2, a anti-apoptotic protein. Conclusions : From the above, the Alisma orientale extract decreased the hepatocyte steatosis and showed the hepatocelluar protective effect by the regulation of apoptosis-related protein. It proposes the possibility of Alisma orientale extract to the treatment of nonalcoholic fatty liver disease in clinics.
Abstract
Objectives : This study was designed to investigate the effect on lipoapoptosis of Alisma orientale extract against free fatty acid-induced cellular injury. Methods : HepG2 cells were used in an vitro model. HepG2 cells were treated with free fatty acids to generate a cellular model of nonalcoholic fatty liver disease (NAFLD). Using this cellular model, the anti-apoptotic effect and reducing steatosis of Alisma orientale extract against free fatty acid-induced cellular injury was evaluated by measuring steatosis and apoptosis. Results : Alisma orientale extract significantly attenuated free fatty acid-induced intracellular steatosis. Alisma orientale extract inhibited free fatty acid-mediated activation of pJNK, PUMA, BAX, caspase-3, and –9, and apoptotic kinases that are correlated with NAFLD. Alisma orientale extract also promoted Bcl-2, a anti-apoptotic protein. Conclusions : From the above, the Alisma orientale extract decreased the hepatocyte steatosis and showed the hepatocelluar protective effect by the regulation of apoptosis-related protein. It proposes the possibility of Alisma orientale extract to the treatment of nonalcoholic fatty liver disease in clinics.
참고문헌 (28)
- Sanyal AJ, "Endpoints and clinical trial design for nonalcoholic steatohepatitis", Hepatology, 54, pp.344~353 (2011)
- Serfaty L, "Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis", Diabetes Metab, 34, pp.634~637 (2008)
- Park SH, "Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 21, pp.138~143 (2006), BLACKWELL PUBLISHING
- Musso G, "Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity", Ann Med, 43(8), pp.617~649 (2010)
- Bellentani S, "Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)", Ann Hepatol, 8(suppl.1), pp.S4~S8 (2009)
- Musso G, "Diagnostic accuracy of adipose insulin resistance index and visceral adiposity index for liver histology and cardiovascular risk in NAFLD", Hepatology, 56(2), pp.788~789 (2012)
- Gregor M, "Thematic review series: Adipocyte biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease", J Lipid Res, 48, pp.1905~1914 (2007)
- 대한간학회, "비알코올 지방간질환 진료 가이드라인", pp.17~27 (2013), 대한간학회
- Xiu RJ, "Microcirculation and traditional Chinese medicine", JAMA, 260, pp.1755~1757 (1988)
- Han CW, "Aqueous extract of Alisma oriental Attenuates palmitate-induced cellular injury by inhibiting production of reactive oxygen species in HepG2 cells", 박사, pp.2010
- Rhew KY, "Antioxidative Effects of Dichloromethane Extract of Alisma orientale on Non-alcoholic Fatty Liver Disease Induced by Methionine and Choline-deficient (MCD) Diet", 박사, pp.2012
- Nehra V, "Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis", Dig Dis Sci, 46(11), pp.2347~2352 (2001)
- McGarry JD, "Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes", Diabetes, 51, pp.7~18 (2002)
- Musso G, "Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis", Hepatology, 37, pp.909~916 (2003)
- De Almeida IT, "Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis", Clin Nutr, 21, pp.219~223 (2002)
- Baylin A, "Adipose tissue biomarkers of fatty acid intake", Am J Clin Nutr, 76, pp.750~757 (2002)
- Ricchi M, "Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes", J Gastroenterol Hepatol, 24(5), pp.830~840 (2009)
- Belfort R, "A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis", N Engl J Med, 355, pp.2297~2307 (2006)
- Lei K, "JNK phosphorylation of Bim-related members of Bcl2 family induces BAX-dependent apoptosis", Natl Acad Sci USA, 100, pp.2432~2437 (2003)
- Yamamoto K, "BCL-2 is phosphorylated and inactivated by an ASK1", Jun N-terminal protein kinase pathway normally activated at G(2), Mol Cell Biol, pp.1999, 19[DOI]
- Jeffers JR, "Puma is an essential mediator of p53-dependent and -independent apoptotic pathways", Cancer Cell, 4, pp.321~328 (2003)
- Luo X, "Transcriptional upregulation of PUMA modulates endoplasmic reticulum calcium pool depletion-induced apoptosis via Bax activation", Cell Death Differ, 12, pp.1310~1318 (2005)
- Taylor RC, "Apoptosis: controlled demolition at the cellular level", Nat Rev Mol Cell Biol, 9(3), pp.231~241 (2008)
- Findly HW, "Expression and regulation of Bcl-2, Bcl-xL, Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia", Blood, 89(8), pp.2986~2993 (1997)
- Ikeda H, "Kuroiwa M. Bcl-2 Oncoprotein Expression and apoptosis in neuroblastoma", Journal of Pediatric surgery, 30(6), pp.805~808 (1996)
- Itoh N, "Effect of bcl-2 on Fas antigen-mediated cell death", The journal of immunology, 151(2), pp.621~627 (1993)
- Ginsberg D, "Wild-type p53 can down-modulate the activity of various promoters", Proc Natl Acad Sci USA, 88(22), pp.9979~9983 (1991)
- Schlesinger PH, "Comparison of the ion channol characteristics of proapoptotic BAX and antiapoptotic BCL-2", proc natl Acad Sci USA, 94(21), pp.11357~11362 (1997)
